Not all patients with CLL require therapy. Regardless of all current advances, the iwCLL still recommends watchful observation for people with asymptomatic condition.86 This recommendation is based on not less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,… Read More